Old Web
English
Sign In
Acemap
>
authorDetail
>
Louis L. Martin
Louis L. Martin
Aventis Pharma
Chemistry
Pharmacology
Pharmacokinetics
Anesthesia
Neprilysin
4
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
No Clinically Relevant CYP3A Induction with the Dual Angiotensin‐Converting Enzyme/Neutral Endopeptidase Inhibitor, M100240
2004
The Journal of Clinical Pharmacology
Nancy E. Martin
Stanley R. Howell
Louis L. Martin
Iolanda Cirillo
Jeffrey S. Barrett
Show All
Source
Cite
Save
Citations (2)
Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteers.
2004
The Journal of Clinical Pharmacology
Gary T. Emmons
Rick Argenti
Louis L. Martin
Nancy E. Martin
Bradford K. Jensen
Show All
Source
Cite
Save
Citations (5)
Pharmacoscintigraphic Assessment of the Regional Drug Absorption of the Dual Angiotensin‐Converting Enzyme/Neutral Endopeptidase Inhibitor, M100240, in Healthy Volunteers
2003
The Journal of Clinical Pharmacology
Nancy E. Martin
Kathryn R. Collison
Louis L. Martin
Sarah Tardif
Ian R. Wilding
Heather Wray
Jeffrey S. Barrett
Show All
Source
Cite
Save
Citations (24)
Site-specific absorption of M100240 and MDL 100,173 in rats evaluated using Sweetana–Grass diffusion chamber technology
2002
Journal of Pharmacological and Toxicological Methods
Kin-Kai Hwang
Lan Jiang
Ying Ren
Louis L. Martin
Nancy E. Martin
Show All
Source
Cite
Save
Citations (3)
1